|
US7361332B2
(en)
*
|
1995-03-17 |
2008-04-22 |
The Regents Of The University Of California |
Treating tumors using implants comprising combinations of allogeneic cells
|
|
US20080220025A1
(en)
*
|
1995-03-17 |
2008-09-11 |
James Thompson |
Treating Tumors Using Implants Comprising Combinations of Allogeneic Cells
|
|
WO1998048000A2
(en)
*
|
1997-04-23 |
1998-10-29 |
The Regents Of The University Of California |
A cell strain with activated anti-cancer cytotoxic activity
|
|
AU9589398A
(en)
|
1997-10-10 |
1999-05-03 |
Applied Immunotherapeutics, Inc. |
Cancer immunotherapy using allostimulated cells in a multiple sequential implantation strategy
|
|
AU9794698A
(en)
|
1997-10-10 |
1999-05-03 |
Regents Of The University Of California, The |
Enhanced immunogenic cell populations prepared using h2 receptor antagonists
|
|
WO1999018981A1
(en)
*
|
1997-10-10 |
1999-04-22 |
The Regents Of The University Of California |
Implants comprising combinations of allogeneic cells for use in cancer treatment
|
|
JP4389039B2
(ja)
*
|
1998-04-09 |
2009-12-24 |
株式会社リンフォテック |
アロジェニックな活性化ｃｄ４陽性細胞を主成分とする医薬組成物、およびその製造方法、ならびに該医薬組成物調製用キット
|
|
US7666609B1
(en)
|
1998-12-01 |
2010-02-23 |
Shanghai Cp Guojian Pharmaceutical Co. Ltd. |
Method and composition for diagnosis of melanocytic lesions
|
|
CN100425287C
(zh)
*
|
1999-02-09 |
2008-10-15 |
理化学研究所 |
肿瘤疫苗
|
|
DK1272617T3
(da)
|
2000-04-01 |
2011-08-22 |
Onyvax Ltd |
Prostata cellelinier og deres anvendelse
|
|
US20080194022A1
(en)
*
|
2000-08-03 |
2008-08-14 |
Clarke Michael F |
Isolation and use of solid tumor stem cells
|
|
US6984522B2
(en)
*
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
|
DE10043437A1
(de)
*
|
2000-09-04 |
2002-03-28 |
Horst Lindhofer |
Verwendung von trifunktionellen bispezifischen und trispezifischen Antikörpern zur Behandlung von malignem Aszites
|
|
US7723111B2
(en)
*
|
2001-03-09 |
2010-05-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Activated dual specificity lymphocytes and their methods of use
|
|
EP1385466B1
(en)
*
|
2001-05-11 |
2011-03-09 |
Wellstat Biologics Corporation |
Oncolytic virus therapy
|
|
US7658926B2
(en)
*
|
2001-09-14 |
2010-02-09 |
Opexa Pharmaceuticals, Inc. |
Autologous T-cell vaccines materials and methods
|
|
EP1293205A1
(en)
*
|
2001-09-18 |
2003-03-19 |
G2M Cancer Drugs AG |
Valproic acid and derivatives thereof for the combination therapy of human cancers, for the treatment of tumour metastasis and minimal residual disease
|
|
CN100422334C
(zh)
*
|
2001-11-27 |
2008-10-01 |
内克西特股份有限公司 |
秀丽新杆线虫中真核生物蛋白质和核酸分子的生产
|
|
KR20020060643A
(ko)
*
|
2002-06-04 |
2002-07-18 |
김진경 |
타인의 면역시스템을 이용하는 암의 치료 방법
|
|
RU2327487C2
(ru)
*
|
2002-08-08 |
2008-06-27 |
Бейлор Колледж Оф Медисин |
Выделение и идентификация т-клеток
|
|
US7571817B2
(en)
*
|
2002-11-06 |
2009-08-11 |
Varco I/P, Inc. |
Automatic separator or shaker with electromagnetic vibrator apparatus
|
|
WO2004075855A2
(en)
|
2003-02-26 |
2004-09-10 |
Biomed Solutions, Llc |
Process for in vivo treatment of specific biological targets in bodily fluid
|
|
KR20040094635A
(ko)
*
|
2003-05-02 |
2004-11-10 |
주식회사 엠디바이오알파 |
항종양 활성의 유도를 위한 종양 백신의 제조방법 및그것을 함유하고 있는 약제 조성물
|
|
US7807784B2
(en)
|
2003-06-11 |
2010-10-05 |
The University Of Chicago |
Increased T-cell tumor infiltration by mutant LIGHT
|
|
US7811983B2
(en)
*
|
2003-06-11 |
2010-10-12 |
The University Of Chicago |
Increased T-cell tumor infiltration and eradication of metastases by mutant light
|
|
US20050019336A1
(en)
|
2003-07-23 |
2005-01-27 |
Dalgleish Angus George |
Human prostate cell lines in cancer treatment
|
|
US7696322B2
(en)
*
|
2003-07-28 |
2010-04-13 |
Catalent Pharma Solutions, Inc. |
Fusion antibodies
|
|
JP2007508018A
(ja)
*
|
2003-10-08 |
2007-04-05 |
べト−ステム インコーポレイテッド |
新規の幹細胞組成物の調製法および使用法、ならびにこの組成物を含有するキット
|
|
US8029454B2
(en)
|
2003-11-05 |
2011-10-04 |
Baxter International Inc. |
High convection home hemodialysis/hemofiltration and sorbent system
|
|
US20050112684A1
(en)
*
|
2003-11-21 |
2005-05-26 |
Eric Holzle |
Class I and Class II MHC Profiling for Social and Sexual Matching of Human Partners
|
|
ES2383306T3
(es)
|
2004-02-03 |
2012-06-20 |
The Regents Of The University Of Michigan |
Composiciones para el tratamiento del cáncer de mama y de páncreas
|
|
US7858323B2
(en)
|
2004-06-09 |
2010-12-28 |
The Regents Of The University Of Michigan |
Phage microarray profiling of the humoral response to disease
|
|
US8257715B1
(en)
|
2004-08-26 |
2012-09-04 |
University Of Notre Dame |
Tissue vaccines and uses thereof
|
|
US9155789B2
(en)
*
|
2005-04-25 |
2015-10-13 |
New York University |
Use of allogenic or syngenic major histocompatibility complex (MHC) molecules as universal adjuvants for vaccines against neoplastic disease, infection and autoimmune disease
|
|
US20090162405A1
(en)
*
|
2006-12-14 |
2009-06-25 |
Yong Qian |
Proteinase-engineered cancer vaccine induces immune responses to prevent cancer and to systemically kill cancer cells
|
|
US8778362B2
(en)
|
2005-10-27 |
2014-07-15 |
University Of Notre Dame |
Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof
|
|
US9308252B2
(en)
*
|
2005-10-27 |
2016-04-12 |
Cook Biotech, Inc. |
Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
|
|
US8778360B2
(en)
*
|
2005-10-27 |
2014-07-15 |
University Of Notre Dame |
Extracellular matrix cancer vaccine adjuvant
|
|
US8802113B2
(en)
*
|
2005-10-27 |
2014-08-12 |
University Of Notre Dame |
Extracellular matrix cancer vaccine adjuvant
|
|
DK2500360T3
(en)
|
2005-10-31 |
2015-10-26 |
Oncomed Pharm Inc |
Compositions and methods for the diagnosis and treatment of cancer
|
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
|
JP5129149B2
(ja)
*
|
2005-10-31 |
2013-01-23 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
癌を処置および診断するための組成物および方法
|
|
WO2008121102A2
(en)
*
|
2006-02-21 |
2008-10-09 |
The Regents Of The University Of Michigan |
Hedgehog signaling pathway antagonist cancer treatment
|
|
WO2007100640A2
(en)
*
|
2006-02-21 |
2007-09-07 |
The Regents Of The University Of Michigan |
Growth hormone receptor antagonist cancer treatment
|
|
CA2651328A1
(en)
*
|
2006-05-05 |
2007-11-15 |
Opexa Therapeutics |
T-cell vaccine
|
|
EP2054444B1
(en)
|
2006-08-04 |
2016-11-02 |
MedImmune Limited |
Antibodies to erbb2
|
|
US7972594B2
(en)
*
|
2006-11-13 |
2011-07-05 |
Immunovative Therapies Ltd. |
Ablative immunotherapy
|
|
US8691568B2
(en)
*
|
2006-11-22 |
2014-04-08 |
Hua Liu |
Method for preparing cell populations with anti-tumor immune response activity
|
|
US20080147007A1
(en)
*
|
2006-12-19 |
2008-06-19 |
Toby Freyman |
Delivery device with pressure control
|
|
WO2008092002A2
(en)
|
2007-01-24 |
2008-07-31 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
|
US8455188B2
(en)
*
|
2007-01-26 |
2013-06-04 |
University Of Louisville Research Foundation, Inc. |
Modification of exosomal components for use as a vaccine
|
|
US20090093429A1
(en)
*
|
2007-02-08 |
2009-04-09 |
Yang-Xin Fu |
Combination therapy for treating cancer
|
|
US8263081B2
(en)
|
2007-05-14 |
2012-09-11 |
The University Of Chicago |
Antibody-light fusion products for cancer therapeutics
|
|
AU2008299318A1
(en)
|
2007-09-12 |
2009-03-19 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Methods of treating tumors in immune-privileged sites
|
|
US8114276B2
(en)
|
2007-10-24 |
2012-02-14 |
Baxter International Inc. |
Personal hemodialysis system
|
|
US9283266B2
(en)
*
|
2008-02-28 |
2016-03-15 |
University Of Notre Dame |
Metastasis inhibition preparations and methods
|
|
CN103002911B
(zh)
|
2008-09-26 |
2015-08-26 |
昂考梅德药品有限公司 |
卷曲蛋白结合药剂及其应用
|
|
AU2009308707A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Biogen Idec Ma Inc. |
LIGHT targeting molecules and uses thereof
|
|
PT2356462T
(pt)
|
2008-11-11 |
2017-04-07 |
Univ Michigan Regents |
Composições e métodos anti-cxcr1
|
|
CU23740A1
(es)
*
|
2009-09-29 |
2011-12-28 |
Ct Ingenieria Genetica Biotech |
Método de obtención de una formulación de antígenos del virus de la hepatitis b
|
|
JP5816627B2
(ja)
*
|
2009-10-27 |
2015-11-18 |
イミュニカム・エイビイ |
抗原特異的ｔ細胞の増殖のための方法
|
|
CN102471753B
(zh)
*
|
2009-12-08 |
2014-10-22 |
伊利诺伊大学理事会 |
干细胞免疫调节应用方法和设备
|
|
US8846059B2
(en)
|
2009-12-08 |
2014-09-30 |
University Of Notre Dame |
Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer
|
|
US20110150934A1
(en)
*
|
2009-12-18 |
2011-06-23 |
University Of Notre Dame |
Ovarian Tumor Tissue Cell Preparations/Vaccines for the Treatment/Inhibition of Ovarian Tumors and Ovarian Cancer
|
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Ｗｎｔ拮抗劑及治療和篩選方法
|
|
US20110237461A1
(en)
|
2010-03-17 |
2011-09-29 |
The Regents Of The University Of Michigan |
Using phage epitopes to profile the immune response
|
|
CA2794674A1
(en)
|
2010-04-01 |
2011-10-06 |
Oncomed Pharmaceuticals, Inc. |
Frizzled-binding agents and uses thereof
|
|
WO2011129348A1
(ja)
*
|
2010-04-13 |
2011-10-20 |
株式会社Ｒｅｉメディカル |
癌組織由来細胞塊または癌細胞凝集塊から得られる癌治療用組成物およびそれを用いた免疫療法剤の製造方法ならびに免疫療法効果評価方法
|
|
WO2012151266A1
(en)
|
2011-05-03 |
2012-11-08 |
Michael Har-Noy |
Methods for handling biological drugs containing living cells
|
|
HRP20211595T1
(hr)
*
|
2011-05-24 |
2022-01-21 |
BioNTech SE |
Individualizirana cjepiva protiv raka
|
|
JP2015501839A
(ja)
|
2011-12-15 |
2015-01-19 |
ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ |
受容体に対する親和性が増大した変異型ｌｉｇｈｔ分子を使用する癌療法のための方法および組成物
|
|
WO2014066328A1
(en)
|
2012-10-23 |
2014-05-01 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating neuroendocrine tumors using wnt pathway-binding agents
|
|
JP2016510411A
(ja)
|
2013-02-04 |
2016-04-07 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
Ｗｎｔ経路インヒビターによる処置の方法およびモニタリング
|
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
|
US20150093416A1
(en)
*
|
2013-09-27 |
2015-04-02 |
Vaccinogen, Inc. |
Autologous tumor vaccines and methods
|
|
MY189857A
(en)
|
2014-11-05 |
2022-03-14 |
Memorial Sloan Kettering Cancer Center |
Methods of selecting t cell line and donor thereof for adoptive cellular therapy
|
|
WO2016145292A1
(en)
*
|
2015-03-12 |
2016-09-15 |
University Of Iowa Research Foundation |
Vaccine, therapeutic composition and methods for treating or inhibiting cancer
|
|
HK1254397A1
(zh)
*
|
2015-06-26 |
2019-07-19 |
纪念斯隆-凯特林癌症中心 |
通过t细胞疗法治疗cmv视网膜炎的方法
|
|
GB2592821B
(en)
|
2015-07-31 |
2022-01-12 |
Univ Minnesota |
Modified cells and methods of therapy
|
|
WO2017087784A1
(en)
|
2015-11-18 |
2017-05-26 |
Duke University |
Tumor infiltrating lymphocytes for treatment of cancer
|
|
JP7181862B2
(ja)
|
2016-10-18 |
2022-12-01 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
腫瘍浸潤リンパ球および治療の方法
|
|
WO2018138682A1
(en)
|
2017-01-26 |
2018-08-02 |
Immune Therapeutics |
Methods and compositions useful for treating cancer
|
|
WO2018224166A1
(en)
|
2017-06-09 |
2018-12-13 |
Biontech Rna Pharmaceuticals Gmbh |
Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy
|
|
WO2019006418A2
(en)
|
2017-06-30 |
2019-01-03 |
Intima Bioscience, Inc. |
ADENO-ASSOCIATED VIRAL VECTORS FOR GENE THERAPY
|
|
KR102256337B1
(ko)
*
|
2017-10-17 |
2021-05-26 |
(주)노터스생명과학 |
조직이식을 위한 세포배양액을 포함하는 면역억제제
|
|
US11446329B2
(en)
|
2017-11-01 |
2022-09-20 |
Restem Llc |
Natural killer cell adoptive transfer therapy for the elimination of senescent PBMCs, reduction of inflammatory cytokines and treatment of IBS
|
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neoantigens
|
|
FR3082730B1
(fr)
|
2018-06-21 |
2022-04-22 |
Med Inn Pharma |
Methode de resolution de l'inflammation pro-tumorale a l'aide d'une preparation pharmaceutique
|
|
WO2023196232A1
(en)
*
|
2022-04-04 |
2023-10-12 |
University Of Florida Research Foundation, Inc. |
Method of characterizing tumors
|
|
CN114984199A
(zh)
*
|
2022-04-19 |
2022-09-02 |
苏州尔生生物医药有限公司 |
一种基于癌症特异性t细胞的细胞系统、淋巴细胞药物及其应用
|